{"title":"第一人称,艾米丽·沃伦","authors":"","doi":"10.1242/dmm.050017","DOIUrl":null,"url":null,"abstract":"\n First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Emily Warren is first author on ‘ 17q12 deletion syndrome mouse model shows defects in craniofacial, brain and kidney development, and glucose homeostasis’, published in DMM. Emily conducted the research described in this article while a postdoctoral fellow in Eric M. Morrow's lab at Brown University, Providence, RI, USA. She is now a postdoctoral fellow in the lab of Peter J. McGuire at the National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI), Bethesda, MD, USA, investigating how metabolic dysfunction impacts the brain, particularly in the context of neurodevelopment and neurodegeneration.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"3 4 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First person – Emily Warren\",\"authors\":\"\",\"doi\":\"10.1242/dmm.050017\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Emily Warren is first author on ‘ 17q12 deletion syndrome mouse model shows defects in craniofacial, brain and kidney development, and glucose homeostasis’, published in DMM. Emily conducted the research described in this article while a postdoctoral fellow in Eric M. Morrow's lab at Brown University, Providence, RI, USA. She is now a postdoctoral fellow in the lab of Peter J. McGuire at the National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI), Bethesda, MD, USA, investigating how metabolic dysfunction impacts the brain, particularly in the context of neurodevelopment and neurodegeneration.\",\"PeriodicalId\":141347,\"journal\":{\"name\":\"Disease Models & Mechanisms\",\"volume\":\"3 4 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2022-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Disease Models & Mechanisms\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1242/dmm.050017\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Disease Models & Mechanisms","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1242/dmm.050017","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
《第一人称》是对发表在《疾病模型与机制》上的论文的第一作者的一系列采访,帮助研究人员在论文的同时提升自己。Emily Warren是《17q12缺失综合征小鼠模型显示颅面、大脑和肾脏发育缺陷以及葡萄糖稳态》的第一作者,发表于《DMM》杂志。艾米丽在美国普罗维登斯布朗大学埃里克·m·莫罗实验室做博士后时进行了本文中描述的研究。她现在是美国国立卫生研究院(NIH)国家人类基因组研究所(NHGRI) Peter J. McGuire实验室的博士后,研究代谢功能障碍如何影响大脑,特别是在神经发育和神经变性的背景下。
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Emily Warren is first author on ‘ 17q12 deletion syndrome mouse model shows defects in craniofacial, brain and kidney development, and glucose homeostasis’, published in DMM. Emily conducted the research described in this article while a postdoctoral fellow in Eric M. Morrow's lab at Brown University, Providence, RI, USA. She is now a postdoctoral fellow in the lab of Peter J. McGuire at the National Institutes of Health (NIH) National Human Genome Research Institute (NHGRI), Bethesda, MD, USA, investigating how metabolic dysfunction impacts the brain, particularly in the context of neurodevelopment and neurodegeneration.